Literature DB >> 626660

Do patients take digoxin?

G D Johnston, J G Kelly, D G McDevitt.   

Abstract

Plasma digoxin concentrations on admission to hospital have been compared with levels on day 8 in a group of 50 patients who were maintained on their preadmission digoxin doses for 7 days. In the absence of a change in renal function, 18 patients (36%) had higher levels on day 8 and were considered to be non-compliant: a further 7 patients (14%) had lower levels on day 8 suggesting that before admission they had been taking more than their prescribed digoxin dose. Fifty per cent were, therefore, taking their digoxin improperly. In addition, an incorrect dose of digoxin may have been prescribed in 14 patients (28%) with plasma digoxin concentrations either below 0.8 ng/ml (1.02nmol/l) or above 2.0 ng/ml (2.56 nmol/l) on day 8. Long-term compliance was assessed by comparing day 8 'steady state' digoxin levels with those obtained at outpatient follow-up. Thirty of the original group were studied at 4 weeks when 27 per cent were considered non-compliant, and 20 at 3 months when 30 per cent were non-compliant. These results have serious implications both for drug prescribing and for the treatment of disease, and suggest that a problem of communication exists between doctors and their patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626660      PMCID: PMC481966          DOI: 10.1136/hrt.40.1.1

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

1.  THE ELDERLY PATIENT AND HIS MEDICATIONS; CHANCE AND MISCHANCE.

Authors:  D SCHWARTZ
Journal:  Geriatrics       Date:  1965-06

2.  Outpatient P.A.S. therapy.

Authors:  W M DIXON; P STRADLING; I D WOOTTON
Journal:  Lancet       Date:  1957-11-02       Impact factor: 79.321

3.  Differences in serum digoxin concentrations between outpatients and inpatients: an effect of compliance?

Authors:  L B Sheiner; B Rosenberg; V V Marathe; C Peck
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

4.  Plasma digoxin concentrations in patients on admission to hospital.

Authors:  S G Carruthers; J G Kelly; D G McDevitt
Journal:  Br Heart J       Date:  1974-07

5.  Bioavailability of digoxin.

Authors:  M C Van Oudtshoorn
Journal:  Lancet       Date:  1972-11-25       Impact factor: 79.321

6.  Variation in the biological availability of digoxin.

Authors:  T R Shaw; M R Howard; J Hamer
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

7.  Altered absorption of digoxin in patients given propantheline and metoclopramide.

Authors:  V Manninen; A Apajalahti; J Melin; M Karesoja
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

8.  Radioimmunoassay of digoxin.

Authors:  K Ojala; J Karjalainen; P Reissell
Journal:  Lancet       Date:  1972-01-15       Impact factor: 79.321

9.  Renal tubular secretion of digoxin.

Authors:  E Steiness
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

10.  To be taken as directed.

Authors:  M S Gatley
Journal:  J R Coll Gen Pract       Date:  1968-07
View more
  13 in total

Review 1.  Allopathy--the therapeutic legacy.

Authors:  G D Johnston
Journal:  Ir J Med Sci       Date:  1989-01       Impact factor: 1.568

Review 2.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 3.  Indications for the measurement of plasma digoxin concentrations.

Authors:  J K Aronson
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

4.  Epidemiology of plasma digoxin concentrations in three patient populations.

Authors:  G D Johnson; D G McDevitt
Journal:  Ir J Med Sci       Date:  1980-02       Impact factor: 1.568

5.  Self-medication with pilocarpine among outpatients in a glaucoma clinic.

Authors:  S E Norell; P A Granström
Journal:  Br J Ophthalmol       Date:  1980-02       Impact factor: 4.638

6.  Patient medication on admission to a medical clinic.

Authors:  U Bergman; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.

Authors:  P Nicod; J Biollaz; B Waeber; J J Goy; R Polikar; J Schlapfer; M D Schaller; G A Turini; J Nussberger; K G Hofbauer
Journal:  Br Heart J       Date:  1986-11

Review 8.  Digoxin toxicity in the aged. Characterising and avoiding the problem.

Authors:  A P Passmore; G D Johnston
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

9.  Gaps in cardiovascular medication taking: the tip of the iceberg.

Authors:  P Rudd; J Ramesh; C Bryant-Kosling; D Guerrero
Journal:  J Gen Intern Med       Date:  1993-12       Impact factor: 5.128

10.  An epidemiological study of digoxin prescribing in general practice.

Authors:  M E Cupples; W G Irwin; D G McDevitt
Journal:  J R Coll Gen Pract       Date:  1986-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.